GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Accumulated other comprehensive income (loss)

Gemina Laboratories (XCNQ:GLAB) Accumulated other comprehensive income (loss) : C$4.42 Mil (As of Jan. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Gemina Laboratories's Accumulated other comprehensive income (loss) for the quarter that ended in Jan. 2025 was C$4.42 Mil.

Gemina Laboratories's quarterly Accumulated other comprehensive income (loss) increased from Jul. 2024 (C$3.81 Mil) to Oct. 2024 (C$3.87 Mil) and increased from Oct. 2024 (C$3.87 Mil) to Jan. 2025 (C$4.42 Mil).

Gemina Laboratories's annual Accumulated other comprehensive income (loss) increased from Jan. 2023 (C$3.33 Mil) to Jan. 2024 (C$3.89 Mil) and increased from Jan. 2024 (C$3.89 Mil) to Jan. 2025 (C$4.42 Mil).

Gemina Laboratories Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Gemina Laboratories's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Accumulated other comprehensive income (loss) Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
Accumulated other comprehensive income (loss)
- 0.89 3.33 3.89 4.42

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.89 4.08 3.81 3.87 4.42

Gemina Laboratories Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Gemina Laboratories Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Gemina Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
TSXV:COV TSX:MDNA TSX:SVA NEOE:ONCO TSXV:MIR TSXV:NRX TSXV:SHRX TSX:HBP TSX:ONC TSX:MBX VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
GLABF:USA
Address
3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Website
https://www.geminalabs.com
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.
Executives
James Damian Tansey Director
Martin Cronin Director
John Davies Director, Director or Senior Officer of 10% Security Holder, Senior Officer

Gemina Laboratories Headlines

No Headlines